title: Surviving life-threatening MDMA (3,4-methylenedioxymethamphetamine, ecstasy) toxicity caused by ritonavir (RTV).
authors.forename: Esther
authors.initials: E
authors.lastname: Papaseit
authors.forename: Antonia
authors.initials: A
authors.lastname: Vázquez
authors.forename: Clara
authors.initials: C
authors.lastname: Pérez-Mañá
authors.forename: Mitona
authors.initials: M
authors.lastname: Pujadas
authors.forename: Rafael
authors.initials: R
authors.lastname: de la Torre
authors.forename: Magí
authors.initials: M
authors.lastname: Farré
authors.forename: Joan
authors.initials: J
authors.lastname: Nolla
mesh_terms: D016913:Blood Component Transfusion; D000075202:Contraindications; D004347:Drug Interactions; D005334:Fever / Q000209:etiology / Q000628:therapy; D005440:Fluid Therapy; D017320:HIV Protease Inhibitors / Q000506:poisoning; D006679:HIV Seropositivity / Q000188:drug therapy*; D006213:Hallucinogens / Q000506:poisoning; D006801:Humans; D007362:Intensive Care Units; D008297:Male; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000506:poisoning*; D006435:Renal Dialysis; D012121:Respiration, Artificial; D019438:Ritonavir / Q000506:poisoning*; D012640:Seizures / Q000209:etiology / Q000628:therapy; D013534:Survival; D014474:Unconsciousness / Q000209:etiology / Q000628:therapy; D055815:Young Adult
chemical_list: D017320:HIV Protease Inhibitors; D006213:Hallucinogens; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D019438:Ritonavir